Drug Design - From Structure and Mode-of-Action to Rational Design Concepts | Agenda Bookshop Skip to content
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
A01=Gerhard Klebe
Age Group_Uncategorized
Age Group_Uncategorized
Author_Gerhard Klebe
automatic-update
Category1=Non-Fiction
Category=MF
Category=MMG
Category=PN
Category=TDCW
COP=Germany
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€50 to €100
PS=Forthcoming
softlaunch

Drug Design - From Structure and Mode-of-Action to Rational Design Concepts

English

By (author): Gerhard Klebe

This English-language textbook, based on the successful German edition 'Wirkstoffdesign', brings the subject of drug design back to the cutting edge of research. The reader learns about new methods in genetic engineering and the expanded range of structural biological methods. Especially in the last 10 years, many complex target structures such as G-protein coupled receptors or ion channels have been elucidated by using these methods. The reader learns how these long-sought complex structures with classical drugs look like and how the therapeutic effect is achieved.

This textbook is aimed at students of pharmacy, chemistry and the life sciences, but also at career changers and medicinal chemists in research and development departments of the pharmaceutical industry. Conceptually, it is very different from classical textbooks on pharmaceutical chemistry. It focuses on the path to a new drug substance. The selection of case studies is based on didactic aspects and attempts to give a broad overview of methods and strategies without forgetting to look back at the beginnings of this field of work. Thus, the arc spans from the history of drug research, the mechanisms of action of drugs and the methods for lead structure search and optimisation to structure determination methods, modelling, molecular dynamics and QSAR methods to structure- and computer-aided design.

This textbook also discusses new methods and concepts such as epigenetics, the PROTAC approach, CRISPR-Cas9 gene scissors, structural predictions from sequence, the use of artificial intelligence and new screening technologies from biophysics. It presents successes in disrupting or enhancing protein-protein interactions as a concept for drug therapy and discusses optimising drugs considering their thermodynamic as well as kinetic binding profiles .

Videos via app: simply download the SN More Media app free of charge, scan a link with the play button and immediately play the video on your smartphone or tablet.

See more
Current price €74.09
Original price €77.99
Save 5%
A01=Gerhard KlebeAge Group_UncategorizedAuthor_Gerhard Klebeautomatic-updateCategory1=Non-FictionCategory=MFCategory=MMGCategory=PNCategory=TDCWCOP=GermanyDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€50 to €100PS=Forthcomingsoftlaunch

Will deliver when available. Publication date 20 Jan 2025

Product Details
  • Dimensions: 210 x 279mm
  • Publication Date: 20 Jan 2025
  • Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
  • Publication City/Country: Germany
  • Language: English
  • ISBN13: 9783662689974

About Gerhard Klebe

Gerhard Klebe is Professor of Pharmaceutical Chemistry at Philipps-Universität Marburg. He retired in April 2020. His research focuses on structure-activity relationships 3D-QSAR methods conformational and pharmacophore analyses docking methods database analyses protein crystallography structure-based drug design and the biophysical characterisation of protein-ligand interactions. Before his appointment in Marburg he taught at the University of Heidelberg and worked in the main laboratory of BASF AG in Ludwigshafen in the field of drug design and crystallography.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept